The slowdown in Medicare spending is largely due to a slowdown in drug spending that might very well reverse itself if the swell of specialty drugs drives up spending as much as some predict, an article in Health Affairs states. The authors, both analysts at the nonpartisan think tank Committee for a Responsible Federal Budget, write that the disproportionate role played by prescription drug spending has somehow mostly escaped attention. “Despite constituting barely more than 10 percent of Medicare...